Similar articles

• Competitive antagonism at thromboxane receptors in human platelets.

  Armstrong RA, Jones RL, Peesapati V, Will SG, Wilson NH. Armstrong RA, et al. Br J Pharmacol. 1985 Mar;84(3):595-607. doi: 10.1111/j.1476-5381.1985.tb16139.x. Br J Pharmacol. 1985. PMID: 2580580 Free PMC article.
• Thromboxane A2, prostacyclin and aspirin: effects on vascular tone and platelet aggregation.

  Smith JB, Araki H, Lefer AM. Smith JB, et al. Circulation. 1980 Dec;62(6 Pt 2):V19-25. Circulation. 1980. PMID: 7002350 Review.
• [Pharmacological action on the thromboxane and prostacyclin balance in the body].

  Lakin KM, Makarov VA, Novikova NV, Tret'iak VM, Rukazenkov IuE. Lakin KM, et al. Farmakol Toksikol. 1984 Mar-Apr;47(2):67-79. Farmakol Toksikol. 1984. PMID: 6425078 Review. Russian. No abstract available.
• Thromboxane-induced phosphatidate formation in human platelets. Relationship to receptor occupancy and to changes in cytosolic free calcium.

  Pollock WK, Armstrong RA, Brydon LJ, Jones RL, MacIntyre DE. Pollock WK, et al. Biochem J. 1984 May 1;219(3):833-42. doi: 10.1042/bj2190833. Biochem J. 1984. PMID: 6234886 Free PMC article.
• Prostaglandin endoperoxides and thromboxane A2 can induce platelet aggregation in the absence of secretion.

  Charo IF, Feinman RD, Detwiler TC, Smith JB, Ingerman CM, Silver MJ. Charo IF, et al. Nature. 1977 Sep 1;269(5623):66-9. doi: 10.1038/269066a0. Nature. 1977. PMID: 895887 No abstract available.